These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Prediction of HIV Drug Resistance by Combining Sequence and Structural Properties. Khalid Z; Sezerman OU IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):966-973. PubMed ID: 27992346 [TBL] [Abstract][Full Text] [Related]
28. MEICPS: substitution mutations to engineer intracellular protein stability. Reddy BV; Ramesh P; Tiwari S Bioinformatics; 1998; 14(2):225-6. PubMed ID: 9545459 [TBL] [Abstract][Full Text] [Related]
29. Automated prediction of HIV drug resistance from genotype data. Shen C; Yu X; Harrison RW; Weber IT BMC Bioinformatics; 2016 Aug; 17 Suppl 8(Suppl 8):278. PubMed ID: 27586700 [TBL] [Abstract][Full Text] [Related]
30. HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors. Hachiya A; Marchand B; Kirby KA; Michailidis E; Tu X; Palczewski K; Ong YT; Li Z; Griffin DT; Schuckmann MM; Tanuma J; Oka S; Singh K; Kodama EN; Sarafianos SG J Biol Chem; 2012 Aug; 287(35):29988-99. PubMed ID: 22761416 [TBL] [Abstract][Full Text] [Related]
33. Using machine learning and big data to explore the drug resistance landscape in HIV. Blassel L; Tostevin A; Villabona-Arenas CJ; Peeters M; Hué S; Gascuel O; PLoS Comput Biol; 2021 Aug; 17(8):e1008873. PubMed ID: 34437532 [TBL] [Abstract][Full Text] [Related]
34. HADDOCK(2P2I): a biophysical model for predicting the binding affinity of protein-protein interaction inhibitors. Kastritis PL; Rodrigues JP; Bonvin AM J Chem Inf Model; 2014 Mar; 54(3):826-36. PubMed ID: 24521147 [TBL] [Abstract][Full Text] [Related]
35. mutLBSgeneDB: mutated ligand binding site gene DataBase. Kim P; Zhao J; Lu P; Zhao Z Nucleic Acids Res; 2017 Jan; 45(D1):D256-D263. PubMed ID: 27907895 [TBL] [Abstract][Full Text] [Related]
36. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy. Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188 [TBL] [Abstract][Full Text] [Related]
37. Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations. He X; Mei Y; Xiang Y; Zhang DW; Zhang JZ Proteins; 2005 Nov; 61(2):423-32. PubMed ID: 16114038 [TBL] [Abstract][Full Text] [Related]
38. DeepPPAPredMut: deep ensemble method for predicting the binding affinity change in protein-protein complexes upon mutation. Nikam R; Jemimah S; Gromiha MM Bioinformatics; 2024 May; 40(5):. PubMed ID: 38718170 [TBL] [Abstract][Full Text] [Related]
39. ClusPro LigTBM: Automated Template-based Small Molecule Docking. Alekseenko A; Kotelnikov S; Ignatov M; Egbert M; Kholodov Y; Vajda S; Kozakov D J Mol Biol; 2020 May; 432(11):3404-3410. PubMed ID: 31863748 [TBL] [Abstract][Full Text] [Related]
40. An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine. Bhakat S; Martin AJ; Soliman ME Mol Biosyst; 2014 Aug; 10(8):2215-28. PubMed ID: 24931725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]